Halofugine prevents cutaneous graft versus host disease by suppression of Th17 differentiation.


Halofuginone, isolated from Dichroa febreifuga, is a potent inhibitor of skin collagen in chronic graft-versus-host disease (GVHD). To evaluate the effect of halofuginone on the development of cutaneous GVHD, we developed a murine model based on BALB/c (H-2d) as recipients with transplantation of C57BL/6(H-2b) bone marrow plus splenocytes. Halofuginone or… (More)
DOI: 10.1179/1607845412Y.0000000016


Figures and Tables

Sorry, we couldn't extract any figures or tables for this paper.

Slides referencing similar topics